ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 411 filers reported holding ENCOMPASS HEALTH CORP in Q4 2021. The put-call ratio across all filers is 0.28 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $277,746 | -86.7% | 4,102 | -89.4% | 0.01% | -88.6% |
| Q1 2023 | $2,094,806 | +384.9% | 38,721 | +402.1% | 0.09% | +450.0% |
| Q2 2022 | $432,000 | -36.9% | 7,712 | -26.5% | 0.02% | -48.4% |
| Q4 2021 | $685,000 | -18.3% | 10,493 | -6.0% | 0.03% | -35.4% |
| Q3 2021 | $838,000 | -58.9% | 11,162 | -57.2% | 0.05% | -63.4% |
| Q2 2021 | $2,037,000 | +164.9% | 26,099 | +177.9% | 0.13% | +244.7% |
| Q1 2021 | $769,000 | +2.8% | 9,391 | +3.8% | 0.04% | +18.8% |
| Q4 2020 | $748,000 | -63.9% | 9,046 | -73.0% | 0.03% | -69.5% |
| Q2 2020 | $2,073,000 | +573.1% | 33,468 | +595.8% | 0.10% | +377.3% |
| Q1 2020 | $308,000 | -84.9% | 4,810 | -83.7% | 0.02% | -75.6% |
| Q4 2019 | $2,046,000 | +655.0% | 29,538 | +588.5% | 0.09% | +542.9% |
| Q3 2019 | $271,000 | +19.9% | 4,290 | +19.9% | 0.01% | +16.7% |
| Q2 2019 | $226,000 | -89.7% | 3,577 | -90.4% | 0.01% | -90.9% |
| Q1 2019 | $2,186,000 | – | 37,423 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JANA PARTNERS LLC | 2,001,897 | $150,222,000 | 11.74% |
| JET CAPITAL INVESTORS L P | 855,100 | $64,167,000 | 10.95% |
| Davide Leone & Partners Investment Co Ltd. | 735,308 | $55,178,000 | 4.23% |
| Kent Lake Capital LLC | 110,000 | $8,254,000 | 3.55% |
| REINHART PARTNERS, LLC. | 604,274 | $53,309,000 | 2.71% |
| AREX Capital Management, LP | 74,000 | $5,553,000 | 2.59% |
| RK Capital | 179,800 | $13,492,000 | 2.55% |
| Orchard Capital Management, LLC | 108,266 | $8,124,000 | 2.44% |
| BARINGTON CAPITAL GROUP, L.P. | 24,200 | $1,816,000 | 1.88% |
| Sivik Global Healthcare LLC | 100,000 | $7,504,000 | 1.79% |